Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for CTVA and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for CTVA and 80,000+ other tickers.
See exactly how CTVA's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CTVA and 80,000+ other tickers.
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers…
On October 06, 2026, Corteva Inc (CTVA) shares rose 12.3% to a current price of $13.91. This move comes amid a 52-week range of $9.08 to $14.44, reflecting a ro
JPMorgan's Overweight call and $19 price target, combined with Corteva's move into the S&P MidCap 400, fueled a 12% surge, today, Oct. 6, 2026.
Corteva completed a spin-off of its advanced seed business earlier this month. JPMorgan revisited its rating on Corteva stock.
Major corporate breakups are reshaping what shareholders own, but one company is doing it twice and another may hand you cash instead of a second stock. Knowing the difference before these deals close could change how you position your portfolio.
Shares of Corteva, Inc. (NYSE: CTVA - Get Free Report) gapped up before the market opened on Tuesday after JPMorgan Chase and Co. upgraded the stock from a neutral rating to an overweight rating. The stock had previously closed at $12.39, but opened at $13.08. JPMorgan Chase and Co. now has a $19.00 price target on